37 results about "Mental symptoms" patented technology

It is intended to provide an agent for improving motor complications accompanying levodopa treatment of Parkinson's disease, delaying the onset of motor complications accompanying levodopa treatment, and inhibiting or delaying the progression of symptoms of Parkinson's disease, comprising a compound represented by the formula (I): a pharmacologically acceptable salt thereof or a hydrate thereof. The compound of the formula (I) has serotonin 1A receptor partial agonistic activity and also has a dopamine D3 receptor agonistic activity without having a dopamine D2 receptor antagonistic activity, has an effect of improving and delaying the onset of motor complications accompanying the repetitive administration of levodopa, and is effective also in accompanying psychiatric symptoms in patients with advanced-stage Parkinson's disease.

The invention relates to a hydroxydecyl quinone derivative for treating or preventing nerve diseases. Specifically, the invention relates to the hydroxydecyl quinone derivative as shown in formula I, a pharmaceutical composition containing the compound as shown in the formula I, and a preparation method and uses of the hydroxydecyl quinone derivative in preparation of medicaments for cerebrovascular diseases. The compound disclosed by the invention can effectively treat or prevent the diseases or disease symptoms: the cerebrovascular diseases, improve cerebral metabolism and improve mental symptoms, activate brain mitochondrial respiratory activity, improve cerebral energy metabolism of cerebral ischemia, improve the utilization rate of cerebral glucose, increase the production of cerebral triphosadenine, inhibit the generation of lipid hydroperoxide from brain mitochondria and inhibit the membrane disorder caused by overoxidation action of the brain mitochondrial membrane lipid, reduce impaired brain functions caused by chronic cerebrovascular diseases, cerebral trauma and the like, improve subjective symptoms, language, anxiety, depression, hypomnesia, intelligence decrease and other mental and behavioral disorders, promote the intelligence, and activate brain mitochondrial functions, improve the cerebral energy metabolism and improve brain functions.

The invention discloses a eurycoma longifolia compound biological preparation and a preparation method thereof. The eurycoma longifolia compound biological preparation is prepared from eurycoma longifolia superfine concentrated solution colla corii asini, radix angelica sinensis, common yam rhizomes, Chinese chive seeds, herba epimedii, fructus lycii, liquorice roots, ursine seal testes and penis, oysters, corn cervi pantotrichum, penis cervi, human placenta and the like through a scientific preparation process. According to the specific symptoms, physical symptoms and mental symptoms of male sexual dysfunction, the male sexual dysfunction is treated wholly, comprehensively and harmoniously by starting from the organism system, and the advantages of being remarkable in clinical curative effect and small in toxic and side effect, treating both symptoms and root causes and the like are achieved.

The invention relates to an oral solid medicine composition for nervous system diseases. The composition is a tablet and comprises an active component, lactose anhydrous, a disintegrating agent and an adhesive. The medicine composition can be used for a cerebrovascular disease, used for improving brain metabolism and mental symptoms, activating respiratory activity of brain mitochondria, improving brain energy metabolism of brain ischemia, increasing a utilization ratio of glucose in a brain, allowing adenosine triphosphate produced in the brain to be increased, preventing brain mitochondrion from generating peroxidized lipin, and inhibiting a membrane obstruction due to lipid peroxidation of a brain mitochondrial membrane, used for brain function injures caused by the chronic cerebrovascular disease, brain trauma and the like, and used for improving mental and behavioral disorders such as a subjective symptom, a language disorder, anxiety, depression, hypomnesia and brain power declining, promoting brain power, activating a brain mitochondrion function, improving the brain energy metabolism and a brain function, improving emotion depression, low consciousness, an affective disorder, a language disorder and the like that are caused by a cerebral infarction sequela, a cerebral hemorrhage sequela and cerebral arteriosclerosis, improving brain metabolism, and protecting cranial neural cells.

The invention belongs to the technical field of medicine and relates to a pharmaceutical composition with an anti-depression effect. The pharmaceutical composition is prepared from, by weight, 5-100 parts of morinda roots, 5-100 parts of fructus gardenia, 5-100 parts of poria cocos and 1-50 parts of fermented soybeans. The pharmaceutical composition is a refined formula determined with the theory of traditional Chinese medicine as the basis and the modern pharmacological study result as indexes, and can remarkably relieve somatic symptoms such as vigor deficiency, sleep disorder and anorexia of patients while treating mental symptoms such as the amorphous type, hebetude, retardation of thinking and bulesis reduction of depression patients.